The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of an incisional hernia.It was reported that after the implant, the patient experienced pain, recurrence, mesh migration and infection.Post-operative patient treatment included revision surgery.
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of an incisional hernia.It was reported that after the implant, the patient experienced pain, adhesions, fistula, recurrence, mesh migration, abscess, purulent drainage, necrosis, ischemia, inflammation, drainage, mesh bunched, tenderness, sinus tract, induration, exudate, fascia attenuated, and infection.Post-operative patient treatment included revision surgery, repair of hernia with mesh, removal of mesh, wound vac placement, exploratory laparotomy, small bowel resection with anastomosis, bilateral abdominal fascial flaps, exploratory celiotomy, lysis of adhesions, resection of fistulae, cholecystectomy, insertion of gastrojejunostomy tube, drain placement, and primary hernia repair.
|